BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26859535)

  • 1. Screening History Among Women with Invasive Cervical Cancer in an Academic Medical Center: Will We Miss Cancers Following Updated Guidelines?
    Nitschmann C; May T; Mirkovic J; Feldman S
    J Womens Health (Larchmt); 2016 Aug; 25(8):826-31. PubMed ID: 26859535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?
    Subramaniam A; Fauci JM; Schneider KE; Whitworth JM; Erickson BK; Kim K; Huh WK
    J Low Genit Tract Dis; 2011 Apr; 15(2):110-3. PubMed ID: 21263352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential effects of updated pap test screening guidelines and adenocarcinoma in situ of the cervix.
    Barroilhet L; Van Hanegem L; Bernstein M; Feldman S
    Obstet Gynecol; 2013 Apr; 121(4):759-764. PubMed ID: 23635675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cervical disease in mature women: strategies for improvement.
    Colgan TJ; Clarke A; Hakh N; Seidenfeld A
    Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
    Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
    PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.
    Zhao L; Wentzensen N; Zhang RR; Dunn ST; Gold MA; Wang SS; Schiffman M; Walker JL; Zuna RE
    Cancer Cytopathol; 2014 Sep; 122(9):694-701. PubMed ID: 24888458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening among women without a cervix.
    Sirovich BE; Welch HG
    JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
    White MC; Shoemaker ML; Benard VB
    Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytological history of 148 women presenting with invasive cervical cancer].
    Mubiayi N; Bogaert E; Boman F; Leblanc E; Vinatier D; Leroy JL; Querleu D
    Gynecol Obstet Fertil; 2002 Mar; 30(3):210-7. PubMed ID: 11998209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.
    Mitchell H; Medley G; Giles G
    BMJ; 1990 Jun; 300(6740):1622-6. PubMed ID: 2372641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix: a case-control study.
    Mitchell H; Hocking J; Saville M
    Acta Cytol; 2004; 48(5):595-600. PubMed ID: 15471249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missed connections: Unintended consequences of updated cervical cancer screening guidelines on screening rates for sexually transmitted infections.
    Bogler T; Farber A; Stall N; Wijayasinghe S; Slater M; Guiang C; Glazier RH
    Can Fam Physician; 2015 Oct; 61(10):e459-66. PubMed ID: 26759845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The screening histories of women with invasive cervical cancer, Connecticut.
    Janerich DT; Hadjimichael O; Schwartz PE; Lowell DM; Meigs JW; Merino MJ; Flannery JT; Polednak AP
    Am J Public Health; 1995 Jun; 85(6):791-4. PubMed ID: 7762711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.